abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention relates to medicine and deals with agent for prevention and treatment of diabetic peripheral neuropathy, which includes as an active agent granulocytic colony-stimulating factor (G-CSF). n EFFECT: invention ensures increase of nerve conduction rate, improvement of pain sensitivity, regeneration of blood vessels in peripheral tissues and rehabilitation of affected nerve tissues. n 6 cl, 2 ex, 7 dwg, 7 tbl |